Background illustration for clinical trials search

Paid Clinical Trials Virginia

Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostate Cancer
Location: Boston MA, Newton MA, Lake Success NY, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: Male

Age: 18+

Code: NCT07244341

Phase1, Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Baltimore MD, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07003295

Phase2, Recruiting

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

for
EGFR Mutation Positive Non-small Cell Lung Cancer,
Location: Calverton MD, Fairfax VA, Pittsburgh PA, Houston TX,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT07315113

Phase1, Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Stony Brook NY, Lake Success NY, Rego Park NY,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06686771

Phase3, Recruiting

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, in Relapse,
Location: Charlottesville VA
Sponsor: Keystone Nano, Inc

Sex: All

Age: 18+

Code: NCT04716452

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for
Duchenne Muscular Dystrophy
Location: Norfolk VA, Durham NC, Gainesville FL, Chicago IL,
Sponsor: Sarepta Therapeutics, Inc.

Sex: Male

Age: 2+

Code: NCT04626674

Phase1, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: New Haven CT, New York NY, Fairfax VA, Durham NC,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, St Louis MO, Houston TX,
Sponsor: FoRx Therapeutics AG

Sex: All

Age: 18+

Code: NCT07356453

Phase1, Recruiting

Strength Training Response of Muscle in GLP-1 Users

for
Muscle Mass
Location: Blacksburg VA
Sponsor: Virginia Polytechnic Institute and State University

Sex: All

Age: 50+

Code: NCT07104539

Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: New York NY, Jersey City NJ, Morehead City NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase3, Recruiting

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

for
Pneumococcal Infection
Location: Columbia MD, East Syracuse NY, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 1

Code: NCT07300267

Phase1, Recruiting

Maternal Newborn Health Registry

for
Pregnancy Outcome Trends in Low-resource Geographic Areas
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: NICHD Global Network for Women's and Children's Health

Sex: All

Age: 0+

Code: NCT01073475

Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Lake Success NY, New York NY, Salem VA, Toronto,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase2, Phase3, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Hackensack NJ, Norfolk VA, Durham NC, Buffalo NY,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase3, Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07349537

Phase1, Recruiting

Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing

for
Cigarette Smoking, E-cigarette Use
Location: Roanoke VA
Sponsor: Virginia Polytechnic Institute and State University

Sex: All

Age: 21+

Code: NCT07161050

Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase2, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Norfolk VA,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Richmond VA, Pittsburgh PA, Atlanta GA, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06980038

Phase2, Recruiting

Popular cities in Virginia

ChesapeakeVirginia BeachRichmondNorfolk